Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-26-086680
Filing Date
2026-07-24
Accepted
2026-07-24 16:57:54
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3/A tm2620954-1_s3a.htm S-3/A 327290
2 EXHIBIT 5.1 tm2620954d2_ex5-1.htm EX-5.1 11108
3 EXHIBIT 23.1 tm2620954d2_ex23-1.htm EX-23.1 2539
4 GRAPHIC lg_replimue-4c.jpg GRAPHIC 28872
5 GRAPHIC tm2620954d2_ex5-1img01.jpg GRAPHIC 3308
6 GRAPHIC tm2620954d2_ex5-1img02.jpg GRAPHIC 953
7 GRAPHIC tm2620954d2_ex5-1img03.jpg GRAPHIC 948
  Complete submission text file 0001104659-26-086680.txt   389500
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

EIN.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: S-3/A | Act: 33 | File No.: 333-287537 | Film No.: 261202171
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)